Meal Provision as a Strategy for Supporting Weight Loss and Improving Metabolic Parameters in Type 2 Diabetes

Meal Replacements for Weight Loss in Type 2 Diabetes in a Community Setting

Background. There is limited information on the effectiveness of meal replacements (MRs) as a weight-loss strategy in an unsupervised community setting. Aim. To evaluate the use of MR compared with a diet book for 6 months. Subjects and Methods. Obese subjects (n = 120) with type 2 diabetes mellitus were recruited from the community in Adelaide, South Australia, and randomised to intervention o...

Is weight loss a cure for type 2 diabetes?

I t has been estimated that 10% of the U.S. population will be diagnosed with type 2 diabetes by the year 2010. Cardiovascular disease accounts for 75% of all related deaths in diabetic patients. While the use of HMG CoA reductase inhibitors has contributed to a marked reduction in mortality in cardiovascular deaths, the benefit in type 2 diabetes has been disappointing. Patients with type 2 di...

Effect of weight loss on metabolic control in people with type 2 diabetes mellitus: systematic review.

OBJECTIVE The aim of this systematic review was to examine randomized clinical trials (RCT) regarding long-term effects of weight loss (WL) on biological markers in people with type 2 diabetes mellitus (T2DM). METHODS We searched for articles published in English and Spanish recorded in the databases of Pubmed and Cochrane , and the journal collections platforms of Ebsco and Scielo between Ja...

Effect of weight loss on metabolic control in people with type 2 diabetes mellitus: systematic review

Weight loss in a UK commercial all meal provision study: a randomised controlled trial

BACKGROUND Effective approaches are needed to address the increasing prevalence of overweight and obesity. The present study investigated whether all meal provision was a more effective and acceptable method for weight loss than a self-directed diet. METHODS This randomised controlled trial recruited 112 men and women with a body mass index in the range 27-35 kg m(-2), who had no comorbiditie...